Dyslipidemia and Other Parameters in Women With Pregnancy Induced Hypertension
Main Article Content
Keywords
.
Abstract
Several investigations have confirmed changes in lipid profiles and other markers (IL-6,CRP ) in women with pregnancy-induced hypertension (PIH). Although, the cause-and-effect correlations between these lipid profiles and other markers with the PIH are yet unknown.
Aim: To study the relationship of serum lipid profile ,C- reactive protein (CRP )and interleukin-6 (IL-6 ) with pregnancy-induced hypertension.
Patients and Methods: A cross- sectional study, was done on 60 pregnant women attending with pregnant induce hypertension (PIH) treated in General Salah Alden Hospital in Tikrit city-Iraq, from January 2021 to April 2021. Other 60 normal pregnant women, at the same period, were selected as a control group. The average age of the participants was (27.1±5.0) years, all the taken blood samples , were examined for lipid profile, CRP and IL-6.
Results: Statistically show significant differences in IL-6 level and CRP. Whereas Lipid profile(TG ,LDL-C HDL-C ,TC and VLDL) were found, also, significant differences in PIH patients as compared to normal controls.
References
1-Dr. Ghada Sayed Youssef. Hypertension in pregnancy, Journal-of-Cardiology-Practice/ Vol. 17, N° 22 - 18 Sep 2019
2- Steer PJ, Little MP, Kold-Jensen T, Chapple J, Elliott P. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.38258.566262.7C (Published 02 December 2004) Cite this as: BMJ 2004;329:1312.
3-Vest AR and Cho LS: Hypertension in pregnancy. Curr Atheroscler Rep. 16:3952014. View Article : Google Scholar : PubMed/NCBI
4-Mangos GJ, Spaan JJ, Pirabhahar S and Brown MA: Markers of cardiovascular disease risk after hypertension in pregnancy. J Hypertens. 30:351–358. 2012. View Article : Google Scholar : PubMed/NCBI
5-Rosengarten D, Blieden LC and Kramer MR: Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J. 40:1304–1305. 2012. View Article : Google Scholar : PubMed/NCBI
6-Lazzarin N, Desideri G, Ferri C, Valensise H, Gagliardi G, Tiralongo GM and Manfellotto D: Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease. Pregnancy Hypertension. 2:393–397. 2012. View Article : Google Scholar : PubMed/NCBI
7-Repke JT: Hypertension in pregnancy. I. Md Med J. 36:473–475. 1987.PubMed/NCBI
8-Babbette LaMarca,1 Joshua Speed,1 Lillian Fournier Ray,1 Kathy Cockrell,1 Gerd Wallukat,2 Ralf Dechend,2 and Joey Granger1 Int J Infereron Cytokine Mediator Res. 2011 Nov; 2011(3): 65–70. doi: 10.2147/IJICMR.S22329.
9- Mohd. Nawaz , Manish Kumar Verma. Evaluation of Differential Levels of Serum Interleukin-6 in Pre-Eclamptic and Normal Pregnancy Women. International Journal of Physiology, January-March 2020, Vol. 8, No. 1.doi:10.5958/2320-608X. 2020.000116.
10- Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M and von Dadelszen P: Community Level Interventions for Pre-eclampsia (CLIP) Working Group: Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: A systematic review. BJOG. 121:1210–1220. 2014. View Article : Google Scholar : PubMed/NCBI
11- Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is a feature of women with early onset preeclampsia. Br J Obstet Gynaecol., 2001; 108: 1081–1087.
12- Cross JC (2003). "The Genetics of Pre-eclampsia: A Feto-placental or Maternal Problem?". Clinical Genetics. 64 (2): 96–103. doi:10.1034/j.1399-0004.2003.00127.x
13- Duckitt K, Harrington D (March 2005). "Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies". BMJ. 330 (7491): 565. doi:10.1136/bmj.38380.674340.E0. PMC 554027. PMID 15743856
14- Dehua Kong, Hui Wang. Yan Liu Hongjun Li, Hongyan Wang Peng Zhu. Correlation between the expression of inflammatory cytokines IL-6, TNF-α and hs-CRP and unfavorable fetal outcomes in patients with pregnancy-induced hypertension . Exper. Therap. Med. 2018;16: 1982-1986.
15-Li Y1,Wang Y2,Ding X3,Duan B3,Li L2,Wang X4.Serum Levels of TNF-α and IL-6 Are Associated With Pregnancy-Induced Hypertension. 12 Apr 2016, 23(10):1402-1408.DOI: 10.1177/1933719116641760 PMID: 27076445
16- Babbette LaMarca, Justin Brewer, and Kedra Wallace. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate: Int J Infereron Cytokine Mediator Res. Author manuscript; available in PMC 2011 Nov 30.)
17-Hala T El-Bassyouni, Sahar M Abdel Raouf, Mona K Farag , Wasela M Nawito, Tarek M Salman, Khaled R Gaber. Dysregulation of tumor necrosis factor-α and interleukin-6 as predictors of gestational disorders
MIDDEL EASTJ OF MEDICAL GENETIC .2018 ; V 7 . Issue : 2 .P 112-117
18- Volanakis JE. Human C-reactive protein: Expression, structure, and function. Mol Immunol. 2001;38:189–197. doi: 10.1016/S0161-5890(01)00042-6. [PubMed] [CrossRef] [Google Scholar]
19- Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2004;18:377–384. doi: 10.1111/j.1365-3016.2004.00578.x. [PubMed] [CrossRef] [Google Scholar
20- Paternoster DM, Fantinato S, Stella A, Nanhornguè KN, Milani M, Plebani M, Nicolini U, Girolami A. C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost. 2006;12:330–337. doi: 10.1177/1076029606291382. [PubMed] [CrossRef] [Google Scholar]
21 - Sesso HD, Buring JE, Rifai N, et al. C-reactive protein and risk of developing hypertension. JAMA 2003;290:2945.-
22- Delia M. Paternoster, Sara Fantinato, Andrea Stella, Kimta Ngaradoumbe Nanhornguè, Massimo Milani, Mario Plebani, Umberto Nicolini, and Antonio Girolami. C-Reactive Protein in Hypertensive Disorders in Pregnancy ‡ Clinical and Applied Thrombosis/Hemostasis Vol. 12, No. 3, July 2006 330-337 DOI: 10.1177/1076029606291382 © 2006 Sage Publications)
23-Hang Chen, Jun Zhang, Fang Qin, Xinyun Chen, and Xiaojing Jiang. Evaluation of the predictive value of high sensitivity C-reactive protein in pregnancy-induced hypertension syndrome. Exp Ther Med. 2018 Aug; 16(2): 619–622. . doi: 10.3892/etm.2018.6246
24- Elena V. Kuklina,. Hypertension in Pregnancy in the US—One Step Closer to Better Ascertainment and Management. JAMA Network Open, 2020. 3(10):e2019364. doi:10.1001/jamanetworkopen.2020.19364.
25- Lowe (2009) Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 49: 242-246.
26- Ray JG, Diamond P, Singh G, Bell CM (2006) Brief overview of maternal triglycerides as a risk factor for pre eclampsia. BJOG 113: 379-386.
27- Butwick AJ, Druzin ML, Shaw GM, Guo N. Evaluation of US state–level variation in hypertensive disorders of pregnancy. JAMA Netw Open. 2020;3(10):e2018741. doi:10.1001/jamanetworkopen.2020.18741
28- Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM (1998) Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism. 47: 1281-1288.
29- Cunningham FG, Leveno KJ, Bloom SL (2005) Williams Obstetrics (22nd edition) New York: McGraw-Hill.
30- Vidyabati RK, Davina H, Singh NK, Singh W. Gyaneshwar-Serum β hCG and lipid profile in early second trimester as predictors of Pregnancy induced hypertension. J Obstet Gynecol India, 2010; 60(1): 44- 50
31- Y. Pramoda. Early predictors of PIH: Serum β-HCG and lipid profile Archives of Integrated Medicine, Vol. 7, Issue 2, February, 2020.
2- Steer PJ, Little MP, Kold-Jensen T, Chapple J, Elliott P. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.38258.566262.7C (Published 02 December 2004) Cite this as: BMJ 2004;329:1312.
3-Vest AR and Cho LS: Hypertension in pregnancy. Curr Atheroscler Rep. 16:3952014. View Article : Google Scholar : PubMed/NCBI
4-Mangos GJ, Spaan JJ, Pirabhahar S and Brown MA: Markers of cardiovascular disease risk after hypertension in pregnancy. J Hypertens. 30:351–358. 2012. View Article : Google Scholar : PubMed/NCBI
5-Rosengarten D, Blieden LC and Kramer MR: Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J. 40:1304–1305. 2012. View Article : Google Scholar : PubMed/NCBI
6-Lazzarin N, Desideri G, Ferri C, Valensise H, Gagliardi G, Tiralongo GM and Manfellotto D: Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease. Pregnancy Hypertension. 2:393–397. 2012. View Article : Google Scholar : PubMed/NCBI
7-Repke JT: Hypertension in pregnancy. I. Md Med J. 36:473–475. 1987.PubMed/NCBI
8-Babbette LaMarca,1 Joshua Speed,1 Lillian Fournier Ray,1 Kathy Cockrell,1 Gerd Wallukat,2 Ralf Dechend,2 and Joey Granger1 Int J Infereron Cytokine Mediator Res. 2011 Nov; 2011(3): 65–70. doi: 10.2147/IJICMR.S22329.
9- Mohd. Nawaz , Manish Kumar Verma. Evaluation of Differential Levels of Serum Interleukin-6 in Pre-Eclamptic and Normal Pregnancy Women. International Journal of Physiology, January-March 2020, Vol. 8, No. 1.doi:10.5958/2320-608X. 2020.000116.
10- Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M and von Dadelszen P: Community Level Interventions for Pre-eclampsia (CLIP) Working Group: Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: A systematic review. BJOG. 121:1210–1220. 2014. View Article : Google Scholar : PubMed/NCBI
11- Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is a feature of women with early onset preeclampsia. Br J Obstet Gynaecol., 2001; 108: 1081–1087.
12- Cross JC (2003). "The Genetics of Pre-eclampsia: A Feto-placental or Maternal Problem?". Clinical Genetics. 64 (2): 96–103. doi:10.1034/j.1399-0004.2003.00127.x
13- Duckitt K, Harrington D (March 2005). "Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies". BMJ. 330 (7491): 565. doi:10.1136/bmj.38380.674340.E0. PMC 554027. PMID 15743856
14- Dehua Kong, Hui Wang. Yan Liu Hongjun Li, Hongyan Wang Peng Zhu. Correlation between the expression of inflammatory cytokines IL-6, TNF-α and hs-CRP and unfavorable fetal outcomes in patients with pregnancy-induced hypertension . Exper. Therap. Med. 2018;16: 1982-1986.
15-Li Y1,Wang Y2,Ding X3,Duan B3,Li L2,Wang X4.Serum Levels of TNF-α and IL-6 Are Associated With Pregnancy-Induced Hypertension. 12 Apr 2016, 23(10):1402-1408.DOI: 10.1177/1933719116641760 PMID: 27076445
16- Babbette LaMarca, Justin Brewer, and Kedra Wallace. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate: Int J Infereron Cytokine Mediator Res. Author manuscript; available in PMC 2011 Nov 30.)
17-Hala T El-Bassyouni, Sahar M Abdel Raouf, Mona K Farag , Wasela M Nawito, Tarek M Salman, Khaled R Gaber. Dysregulation of tumor necrosis factor-α and interleukin-6 as predictors of gestational disorders
MIDDEL EASTJ OF MEDICAL GENETIC .2018 ; V 7 . Issue : 2 .P 112-117
18- Volanakis JE. Human C-reactive protein: Expression, structure, and function. Mol Immunol. 2001;38:189–197. doi: 10.1016/S0161-5890(01)00042-6. [PubMed] [CrossRef] [Google Scholar]
19- Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2004;18:377–384. doi: 10.1111/j.1365-3016.2004.00578.x. [PubMed] [CrossRef] [Google Scholar
20- Paternoster DM, Fantinato S, Stella A, Nanhornguè KN, Milani M, Plebani M, Nicolini U, Girolami A. C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost. 2006;12:330–337. doi: 10.1177/1076029606291382. [PubMed] [CrossRef] [Google Scholar]
21 - Sesso HD, Buring JE, Rifai N, et al. C-reactive protein and risk of developing hypertension. JAMA 2003;290:2945.-
22- Delia M. Paternoster, Sara Fantinato, Andrea Stella, Kimta Ngaradoumbe Nanhornguè, Massimo Milani, Mario Plebani, Umberto Nicolini, and Antonio Girolami. C-Reactive Protein in Hypertensive Disorders in Pregnancy ‡ Clinical and Applied Thrombosis/Hemostasis Vol. 12, No. 3, July 2006 330-337 DOI: 10.1177/1076029606291382 © 2006 Sage Publications)
23-Hang Chen, Jun Zhang, Fang Qin, Xinyun Chen, and Xiaojing Jiang. Evaluation of the predictive value of high sensitivity C-reactive protein in pregnancy-induced hypertension syndrome. Exp Ther Med. 2018 Aug; 16(2): 619–622. . doi: 10.3892/etm.2018.6246
24- Elena V. Kuklina,. Hypertension in Pregnancy in the US—One Step Closer to Better Ascertainment and Management. JAMA Network Open, 2020. 3(10):e2019364. doi:10.1001/jamanetworkopen.2020.19364.
25- Lowe (2009) Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 49: 242-246.
26- Ray JG, Diamond P, Singh G, Bell CM (2006) Brief overview of maternal triglycerides as a risk factor for pre eclampsia. BJOG 113: 379-386.
27- Butwick AJ, Druzin ML, Shaw GM, Guo N. Evaluation of US state–level variation in hypertensive disorders of pregnancy. JAMA Netw Open. 2020;3(10):e2018741. doi:10.1001/jamanetworkopen.2020.18741
28- Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM (1998) Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism. 47: 1281-1288.
29- Cunningham FG, Leveno KJ, Bloom SL (2005) Williams Obstetrics (22nd edition) New York: McGraw-Hill.
30- Vidyabati RK, Davina H, Singh NK, Singh W. Gyaneshwar-Serum β hCG and lipid profile in early second trimester as predictors of Pregnancy induced hypertension. J Obstet Gynecol India, 2010; 60(1): 44- 50
31- Y. Pramoda. Early predictors of PIH: Serum β-HCG and lipid profile Archives of Integrated Medicine, Vol. 7, Issue 2, February, 2020.
Article Sidebar
Published
Apr 12, 2022
Article Details
How to Cite
Alaa Saber Shihab, Maha Arshad Hamdi, Abdulhadi Mohamed Jumaa, Mousa Mahmoud Marbut, & Sahar Kamel Jwad. (2022). Dyslipidemia and Other Parameters in Women With Pregnancy Induced Hypertension. Journal of Population Therapeutics and Clinical Pharmacology, 29(01). https://doi.org/10.47750/jptcp.2022.900
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.